Jefferies Financial Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.74M Buy
114,308
+89,131
+354% +$3.21M 0.02% 463
2026
Q1
$890K Buy
25,177
+20,179
+404% +$821K 0.01% 974
2025
Q4
$203K Sell
4,998
-8,473
-63% -$369K ﹤0.01% 1619
2025
Q3
$634K Sell
13,471
-84,529
-86% -$4.38M ﹤0.01% 1010
2025
Q2
$5.1M Buy
98,000
+19,386
+25% +$1.06M 0.04% 295
2025
Q1
$4.75M Buy
78,614
+68,295
+662% +$4.4M 0.04% 304
2024
Q4
$706K Buy
+10,319
New +$719K ﹤0.01% 1004
2024
Q2
– Sell
-48,315
Closed -$3.87M – 1472
2024
Q1
$3.87M Sell
48,315
-86,085
-64% -$7.67M 0.04% 375
2023
Q4
$14.7M Buy
134,400
+126,148
+1,529% +$13M 0.1% 152
2023
Q3
$832K Buy
8,252
+6,113
+286% +$702K 0.01% 887
2023
Q2
$291K Buy
+2,139
New +$261K ﹤0.01% 1332
2023
Q1
– Sell
-62,878
Closed -$5.57M – 1677
2022
Q4
$5.57M Buy
+62,878
New +$5.22M 0.04% 381

Other funds holding CNMD

Jefferies Financial Group's CNMD Position: Q2 2026 in Review

Jefferies Financial Group increased its CONMED (CNMD) stake by 354% in Q2 2026, buying an estimated $3.21M and bringing the position to 114,308 shares worth $3.74M. The position accounts for 0.02% of the portfolio, ranked #463.

Jefferies Financial Group first reported a position in CNMD in Q4 2022 and has held it in 12 quarters since. The position peaked at $14.7M in Q4 2023. 246 funds tracked by Wall St. Rank hold CNMD as of Q2 2026.

  • Jefferies Financial Group held 114,308 shares of CONMED worth $3.74M as of Q2 2026.
  • Jefferies Financial Group bought 89,131 CONMED shares in Q2 2026, an estimated $3.21M.
  • CONMED made up 0.02% of Jefferies Financial Group's portfolio in Q2 2026, its #463 holding.
  • Jefferies Financial Group first reported a position in CONMED in Q4 2022 and has held it in 12 quarters since.
  • Jefferies Financial Group's CONMED position peaked at $14.7M in Q4 2023.
  • 246 funds tracked by Wall St. Rank held CONMED as of Q2 2026.

Based on Jefferies Financial Group's 13F filing for Q2 2026, filed 17 Aug 2026.